ARCHIVES

FDA Committee Oks AMSA for Group C List, Tables THC Request, Deadlocks On Estramustine NDA

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

NIH Workshop On Animal Care Planned

May 4, 1990

Komen Foundation Announces Second Grant Cycle For 1995

April 28, 1995

Karmanos Cancer Center Wins $4.6M From U.S. Army.

September 5, 2008

Text Of Working Group’s Recommendations

May 19, 1995

Lymphatic Mapping Techniques Can Outperform “Watch-and-Wait”

February 28, 2014